|
1
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tu CC and Hsu PK: The frontline of
esophageal cancer treatment: Questions to be asked and answered.
Ann Transl Med. 6:832018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kimura M, Ishiguro H, Tanaka T and
Takeyama H: Advanced esophageal cancer with tracheobronchial
fistula successfully treated by esophageal bypass surgery. Int J
Surg Case Rep. 9:115–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li B, Hong P, Zheng CC, Dai W, Chen WY,
Dai W, Chen WY, Yang QS, Han L, Tsao SW, et al: Identification of
miR-29c and its target FBXO31 as a key regulatory mechanism in
esophageal cancer chemoresistance: Functional validation and
clinical significance. Theranostics. 9:1599–1613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siersema PD: Esophageal cancer awareness
issue 2019. Endoscopy. 51:291–292. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang N, Yin Y, Xu SJ and Chen WS:
5-Fluorouracil: Mechanisms of resistance and reversal strategies.
Molecules. 13:1551–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vodenkova S, Buchler T, Cervena K,
Veskrnova V, Vodicka P and Vymetalkova V: 5-Fluorouracil and other
fluoropyrimidines in colorectal cancer: Past, present and future.
Pharmacol Ther. 206:1074472020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Acuna-Castroviejo D, Escames G, Venegas C,
Diaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX
and Reiter RJ: Extrapineal melatonin: Sources, regulation, and
potential functions. Cell Mol Life Sci. 71:2997–3025. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Claustrat B and Leston J: Melatonin:
Physiological effects in humans. Neurochirurgie. 61:77–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Talib WH: Melatonin and cancer hallmarks.
Molecules. 23:5182018. View Article : Google Scholar
|
|
12
|
Cardinali DP: Melatonin: Clinical
perspectives in neurodegeneration. Front Endocrinol (Lausanne).
10:4802019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Yang XZ, Xu MJ, Huang GY, Zhang
Q, Cheng YX, He L and Ren HY: Melatonin promotes cheliped
regeneration, digestive enzyme function, and immunity following
autotomy in the Chinese mitten crab, eriocheir sinensis. Front
Physiol. 9:2692018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou N, Wei ZX and Qi ZX: Inhibition of
autophagy triggers melatonin-induced apoptosis in glioblastoma
cells. BMC Neurosci. 20:632019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu K, Wang J, Liu H, Zhao J and Lu W:
Melatonin promotes the proliferation of chicken sertoli cells by
activating the ERK/Inhibin alpha subunit signaling pathway.
Molecules. 25:12302020. View Article : Google Scholar
|
|
16
|
Song J, Ma SJ, Luo JH, Zhang H, Wang RX,
Liu H, Li L, Zhang ZG and Zhou RX: Melatonin induces the apoptosis
and inhibits the proliferation of human gastric cancer cells via
blockade of the AKT/MDM2 pathway. Oncol Rep. 39:1975–1983.
2018.PubMed/NCBI
|
|
17
|
Xiang S, Dauchy RT, Hoffman AE, Pointer D,
Frasch T, Blask DE and Hill SM: Epigenetic inhibition of the tumor
suppressor ARHI by light at night-induced circadian melatonin
disruption mediates STAT3-driven paclitaxel resistance in breast
cancer. J Pineal Res. 67:e125862019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Q, Sun Z, Du L, Xu C, Wang Y, Yang B,
He N, Wang J, Ji K, Liu Y and Liu Q: Melatonin sensitizes human
colorectal cancer cells to γ-ray ionizing radiation in vitro and in
vivo. Int J Mol Sci. 19:39742018. View Article : Google Scholar
|
|
19
|
Hao J, Fan W, Li Y, Tang R, Tian C, Yang
Q, Zhu T, Diao C, Hu S, Chen M, et al: Melatonin synergizes
BRAF-targeting agent vemurafenib in melanoma treatment by
inhibiting iNOS/hTERT signaling and cancer-stem cell traits. J Exp
Clin Cancer Res. 38:482019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leja-Szpak A, Nawrot-Porąbka K, Góralska
M, Jastrzębska M, Link-Lenczowski P, Bonior J, Pierzchalski P and
Jaworek J: Melatonin and its metabolite
N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance
chemosensitivity to gemcitabine in pancreatic carcinoma cells
(PANC-1). Pharmacol Rep. 70:1079–1088. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bae WK and Hennighausen L: Canonical and
non-canonical roles of the histone methyltransferase EZH2 in
mammary development and cancer. Mol Cell Endocrinol. 382:593–597.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Yang X, Li R, Zhang R, Hu D, Zhang
Y and Gao L: LncRNA SNHG6 inhibits apoptosis by regulating EZH2
expression via the sponging of MiR-101-3p in esophageal
squamous-cell carcinoma. Onco Targets Ther. 13:11411–11420. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang C, Li X, Zhang J, Ge Z, Chen H and Hu
J: EZH2 contributes to 5-FU resistance in gastric cancer by
epigenetically suppressing FBXO32 expression. Onco Targets Ther.
11:7853–7864. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rastgoo N, Pourabdollah M, Abdi J, Reece D
and Chang H: Dysregulation of EZH2/miR-138 axis contributes to drug
resistance in multiple myeloma by downregulating RBPMS. Leukemia.
32:2471–2482. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng X, Pang B, Gu G, Gao T, Zhang R,
Pang Q and Liu Q: Melatonin inhibits glioblastoma stem-like cells
through suppression of EZH2-NOTCH1 signaling axis. Int J Biol Sci.
13:245–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen X, Hao A, Li X, Du Z, Li H, Wang H,
Yang H and Fang Z: Melatonin inhibits tumorigenicity of
glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
J Pineal Res. 61:208–217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Z, Jiang C and Yuan Y: TCGA based
integrated genomic analyses of ceRNA network and novel subtypes
revealing potential biomarkers for the prognosis and target therapy
of tongue squamous cell carcinoma. PLoS One. 14:e02168342019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Li R, Ding X, Zhang K and Qin W:
Upregulation of long non-coding RNA SNHG6 promote esophageal
squamous cell carcinoma cell malignancy and its diagnostic value.
Am J Transl Res. 11:1084–1091. 2019.PubMed/NCBI
|
|
30
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reiter RJ, Rosales-Corral SA, Tan DX,
Acuna-Castroviejo D, Qin L, Yang SF and Xu K: Melatonin, a full
service anti-cancer agent: Inhibition of initiation, progression
and metastasis. Int J Mol Sci. 18:8432017. View Article : Google Scholar
|
|
32
|
Hill SM, Belancio VP, Dauchy RT, Xiang S,
Brimer S, Mao L, Hauch A, Lundberg PW, Summers W, Yuan L, et al:
Melatonin: An inhibitor of breast cancer. Endocr Relat Cancer.
22:R183–R204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen YT, Yang CC, Shao PL, Huang CR and
Yip HK: Melatonin-mediated downregulation of ZNF746 suppresses
bladder tumorigenesis mainly through inhibiting the AKT-MMP-9
signaling pathway. J Pineal Res. 66:e125362019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao Y, Xiao X, Zhang C, Yu W, Guo W, Zhang
Z, Li Z, Feng X, Hao J, Zhang K, et al: Melatonin synergizes the
chemotherapeutic effect of 5-fluorouracil in colon cancer by
suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. J Pineal
Res. 62:e123802017. View Article : Google Scholar
|
|
35
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
